Adiponectin: An endothelium-derived vasoprotective factor?

Current Vascular Pharmacology

Volumn 14, Issue 2, 2016, Pages 168-174

  Shen, Lei ^a   Evans, Ian M ^a   Souza, Domingos ^b   Dreifaldt, Mats ^b   Dashwood, Michael R ^c   Vidya, Mohamed Ali ^a,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Örebro University   (Sweden)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d Anti Doping Lab Qatar ^*  (Qatar)

Author keywords

Adiponectin; Coronary artery bypass grafting; Endothelium; Perivascular adipose tissue

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CYTOKINE; PROTECTIVE AGENT;

ADIPOSE TISSUE; ARTICLE; CORONARY ARTERY BYPASS GRAFT; ENDOTHELIUM; EPICARDIAL FAT; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERNAL MAMMARY ARTERY; KIDNEY; OBESITY; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION; ANIMAL; CHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADIPONECTIN; ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; PROTECTIVE AGENTS; SIGNAL TRANSDUCTION;

EID: 85017070133     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/1570161114666151202210128     Document Type: Article

References (53)

1. Goncalves N, Falcao-Pires I, Leite-Moreira, AF. Adipokines and their receptors: potential new targets in cardiovascular diseases. Future Med Chem 2015; 7(2): 139-57.
2. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257(1): 79-83.
3. Kadowaki T, Yamauchi T, Kubota N, et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116(7): 1784-92;
4. Frystyk J, Berne C, Berglund L, et al. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 2007; 92(2): 571-6.
5. Wong GW, Wang J, Hug C, et al. A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci USA 2004; 101(28): 10302-7;
6. Kadowaki T, Yamauchi T. Adiponectin and Adiponectin Receptors. Endocr Rev 2005; 26(3): 439-51.
7. Hattori Y, Hattori S, Akimoto K, et al. Globular adiponectin activates nuclear factor-kappaB and activating protein-1 and enhances angiotensin II-induced proliferation in cardiac fibroblasts. Diabetes 2007; 56(3): 804-8.
8. Pajvani UB, Hawkins M, Combs TP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004; 279(13): 12152-62.
9. Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001; 98(4): 2005-10;
10. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423(6941): 762-9.
11. Yamauchi T, Nio Y, Maki T, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 2007; 13(3): 332-9.
12. Tsuchida A, Yamauchi T, Ito Y, et al. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 2004; 279(29): 30817-22;
13. Christou GA, Kiortsis DN. The role of adiponectin in renal physiology and development of albuminuria. J Endocrinol 2014; 221(2): R49-61.
14. Zoccali C, Mallamaci F, Adiponectin and leptin in chronic kidney disease: causal factors or mere risk markers? J Ren Nutr 2011; 21(1): 87-91.
15. Perri A, Vizza D, Lofaro D, et al. Adiponectin is expressed and secreted by renal tubular epithelial cells. J Nephrol 2013; 26(6): 1049-54.
16. Mohar DS, Salcedo J, Hoang KC, et al. Epicardial adipose tissue volume as a marker of coronary artery disease severity in patients with diabetes independent of coronary artery calcium: findings from the CTRAD study. Diabetes Res Clin Pract 2014; 106(2): 228-35.
17. Lima-Martínez MM, López-Mendez G, Odreman R, Donis JH, Paoli M. Epicardial adipose tissue thickness and its association with adiponectin in metabolic syndrome patients from Merida, Venezuela. Arq Bras Endocrinol Metabol 2014; 58(4): 352-61.
18. Fujita K, Maeda N, Sonoda M, et al. Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha. Arterioscler Thromb Vasc Biol 2008; 28(5): 863-70.
19. Gu P, Xu AM. Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction. Rev Endocr Metab Disord 2013; 14(1): 49-58.
20. Fantuzzi G, Mazzone T. Adipose tissue and atherosclerosis -Exploring the connection. Arterioscl Throm Vas 2007; 27(5): 996-1003.
21. Shimabukuro M, Higa N, Asahi T, et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 2003; 88(7): 3236-40;
22. Ouchi N, Ohishi M, Kihara S, et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003; 42(3): 231-4.
23. Lisowska A, Lisowski P, Knapp M, et al. Serum adiponectin and markers of endothelial dysfunction in stable angina pectoris patients undergoing Coronary Artery Bypass Grafting (CABG). Adv Med Sci 2014; 59(2): 245-9.
24. Okamoto Y, Arita Y, Nishida M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000; 32(2): 47-50.
25. Komura N, Maeda N, Mori T, et al. Adiponectin protein exists in aortic endothelial cells. PLoS One 2013; 8(8): e71271.
26. Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002; 277(40): 37487-91.
27. Ebrahimi-Mamaeghani M, Mohammadi S, Arefhosseini SR, et al. Adiponectin as a potential biomarker of vascular disease. Vasc Health Risk Manag 2015; 11: 55-70.
28. Lee RM, Lu C, Su LY, et al. Endothelium-dependent relaxation factor released by perivascular adipose tissue. J Hypertens 2009; 27(4): 782-90.
29. Lohn M, Dubrovska G, Lauterbach B, et al. Periadventitial fat releases a vascular relaxing factor. FASEB J 2002; 16(9): 1057-63;
30. Gao YJ, Lu C, Su LY, et al. Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br J Pharmacol 2007; 151(3): 323-31.
31. Omae T, Nagaoka T, Tanano I, et al. Adiponectin-induced dilation of isolated porcine retinal arterioles via production of nitric oxide from endothelial cells. Invest Ophthalmol Vis Sci 2013; 54(7): 4586-94.
32. Greenstein AS, Khavandi K, Withers SB, et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009; 119(12): 1661-70.
33. Lynch FM, Withers SB, Yao Z, et al. Perivascular adipose tissue-derived adiponectin activates BK(Ca) channels to induce anticontractile responses. Am J Physiol Heart Circ Physiol 2013; 304(6): H786-795.
34. Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102(11): 1296-1301.
35. Chen H, Montagnani M, Funahashi T, et al. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003; 278(45): 45021-6.
36. Molica F, Morel S, Kwak BR, et al. Adipokines at the crossroad between obesity and cardiovascular disease. Thromb Haemost 2015; 113(3): 553-66.
37. Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003; 107(5): 671-4.
38. Fasshauer M, Kralisch S, Klier M, et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2003; 301(4): 1045-50.
39. Hotamisligil GS, Shargill NS, Spiegelman BM, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259(5091): 87-91.
40. Okamoto Y, Kihara S, Ouchi N, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002; 106(22): 2767-70.
41. Li CJ, Sun HW, Zhu FL, et al. Local adiponectin treatment reduces atherosclerotic plaque size in rabbits. J Endocrinol 2007; 193(1): 137-45.
42. Cai X, Li X, Li L, et al. Adiponectin reduces carotid atherosclerotic plaque formation in ApoE-/- mice: roles of oxidative and nitrosative stress and inducible nitric oxide synthase. Mol Med Rep 2015; 11(3): 1715-21.
43. Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 2007; 100(2): 158-73.
44. Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 2007; 100(2): 174-90.
45. Scott DW, Vallejo MO, Patel RP. Heterogenic endothelial responses to inflammation: role for differential N-glycosylation and vascular bed of origin. J Am Heart Assoc 2013; 2(4): e000263;
46. Cheng KK, Lam KS, Wang Y, et al. Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 2007; 56(5): 1387-94.
47. Schmid PM, Resch M, Schach C, et al. Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats. Cardiovasc Diabetol 2013; 12: 46.
48. Planat-Benard V, Silvestre JS, Cousin B, et al. Plasticity of human adipose lineage cells toward endothelial cells - Physiological and therapeutic perspectives. Circulation 2004; 109(5): 656-63.
49. Gupta RK, Mepani RJ, Kleiner S, et al. Zfp423 Expression Identifies Committed Preadipocytes and Localizes to Adipose Endothelial and Perivascular Cells. Cell Metab 2012; 15(2): 230-9.
50. Tschritter O, Fritsche A, Thamer C, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003; 52(2): 239-43.
51. Karastergiou K, Evans I, Ogston N, et al. Epicardial adipokines in obesity and coronary artery disease induce atherogenic changes in monocytes and endothelial cells. Arterioscler Thromb Vasc Biol 2010; 30(7): 1340-6.
52. Souza DS, Johansson B, Bojo L, et al. Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: results of a randomized longitudinal trial. J Thorac Cardiovasc Surg 2006; 132(2): 373-8.
53. Sims FH. A comparison of coronary and internal mammary arteries and implications of the results in the etiology of arteriosclerosis. Am Heart J 1983; 105(4): 560-6.